Transcutaneous tibial nerve stimulation to treat primary dysmenorrhea in adolescents. A Double-blind randomized placebo controlled trial.
Journal of Pediatric and Adolescent Gynecology · 2026
DOI: 10.1016/j.jpag.2026.01.044 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Pediatric and Adolescent Gynecology, 2026. Verfasst von Valentín Manríquez und 5 weiteren Autor:innen. Beteiligte Einrichtung: Unidad de Piso Pélvico Femenino, Departamento de Obstetricia y Ginecología, Hospital Clínico Universidad de Chile, Santiago, Chile. Hauptthemen laut MEDLINE: Dysmenorrhea, Transcutaneous Electric Nerve Stimulation, Tibial Nerve. Die Arbeit nennt 24 Literaturangaben. Gefördert von: CONICYT FONDECYT.
Abstract (Originalsprache)
OBJECTIVE: To evaluate the effectiveness and safety of transcutaneous posterior tibial nerve stimulation (TC-TNS) to treat primary dysmenorrhea in adolescents METHODS: A double-blind, block-randomized controlled clinical trial, approved by the local Ethical Committee, was conducted. Adolescents between 12 and 19 years old with menstrual pain were included. Patients with secondary dysmenorrhea, who used hormonal contraception or intrauterine devices, who were pregnant, who requested contraception, who had contraindications to use nonsteroidal anti-inflammatory drugs, or who had intellectual disabilities were excluded. A total of 87 adolescents were randomized into 2 groups: group 1 received mefenamic acid during the first 3 days of the menstrual cycle and sham TC-TNS sessions (30 minutes each) 3 times per week for 8 weeks, and group 2 received an oral placebo during the first 3 days of menstruation and active TC-TNS sessions (30 minutes each) 3 times per week for 8 weeks. Clinical evaluations were conducted after 4 and 8 weeks. The main outcome was the reduction in menstrual pain, assessed with the visual analog scale. RESULTS: Both groups experienced clinically significant relief of their pain, with no differences between the groups. CONCLUSION: TC-TNS produces a reduction in primary dysmenorrhea in adolescents that is comparable to the effect achieved by mefenamic acid and could be considered as a therapeutic alternative, as it is free of adverse effects and self-applicable.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Unidad de Piso Pélvico Femenino, Departamento de Obstetricia y Ginecología, Hospital Clínico Universidad de Chile, Santiago, Chile.
- Centro de Medicina Reproductiva y Desarrollo Integral de la Adolescencia (CEMERA), Facultad de Medicina, Universidad de Chile, Santiago, Chile.
- Unidad de Piso Pélvico Femenino, Departamento de Obstetricia y Ginecología, Hospital Clínico Universidad de Chile, Santiago, Chile; Departamento de Ginecologia y Obstetricia, Facultad de Medicina, Clinica Alemana de San…
- Oficina de Apoyo a la Investigación Clínica, Hospital Clínico Universidad de Chile, Santiago, Chile.
Förderung
- CONICYT FONDECYT
Zitieren
APA
Manríquez, V., Troncoso, P., Pastene, C., Naser, M., Vallejos-Penaloza, G., & Castro, A. (2026). Transcutaneous tibial nerve stimulation to treat primary dysmenorrhea in adolescents. A Double-blind randomized placebo controlled trial. Journal of Pediatric and Adolescent Gynecology. https://doi.org/10.1016/j.jpag.2026.01.044
Vancouver
Manríquez V, Troncoso P, Pastene C, Naser M, Vallejos-Penaloza G, Castro A. Transcutaneous tibial nerve stimulation to treat primary dysmenorrhea in adolescents. A Double-blind randomized placebo controlled trial. Journal of Pediatric and Adolescent Gynecology. 2026. doi:10.1016/j.jpag.2026.01.044
BibTeX
@article{Manrquez2026,
author = {Manríquez, Valentín and Troncoso, Paulina and Pastene, Carolina and Naser, Michel and Vallejos-Penaloza, Gabriel and Castro, Ariel},
title = {Transcutaneous tibial nerve stimulation to treat primary dysmenorrhea in adolescents. A Double-blind randomized placebo controlled trial},
journal = {Journal of Pediatric and Adolescent Gynecology},
year = {2026},
doi = {10.1016/j.jpag.2026.01.044}
}
EUVIMED